Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44358 clinical trials with a EudraCT protocol, of which 7384 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,358)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,358 result(s) found. Displaying page 99 of 2,218.

EudraCT Number: 2008-008721-29

Sponsor Protocol Number: KYT62121/2008-01

Start Date*: 2009-11-19

Sponsor Name:Merck Selbstmedikation GmbH

Full Title: Double-blind, randomised, multi-centre, placebo-controlled clinical trail to investigate the efficacy and safety of a combination of comfrey root extract plus methyl nicotinate versus a preparation...

Medical condition: Acute upper or low back pain as described in the note for guidance on clinical investigation of medical products for treatment of Nociceptive Pain (CPMP/EWP/612/00. Nov. 21, 2002)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10000683	Acute back pain	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2008-008731-28	Sponsor Protocol Number: DPM-B-305	Start Date*: 2009-06-05
Sponsor Name:Pharmaxis Pharmaceuticals Limited
Full Title: A phase III multicentre, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol over 12 months in the treatment of bronchiectasis.
Medical condition: Bronchiectasis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed) DE (Completed) NL (Completed) BE (Completed)
Trial results: View results

EudraCT Number: 2009-012456-25

Sponsor Protocol Number: B1451006

Start Date*: 2009-12-21

Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017

Full Title: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 26-WEEK TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF DIMEBON (LATREPIRDINE, PF-01913539) IN PATIENTS WITH MODERATE-TO-SEVERE AL...

Medical condition: Alzheimer's Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10001896	Alzheimer's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) PT (Prematurely Ended) HU (Prematurely Ended) ES (Prematurely Ended) CZ (Prematurely Ended) SK (Prematurely Ended)

Trial results: View results

EudraCT Number: 2009-012741-27

Sponsor Protocol Number: 08-090

Start Date*: 2010-06-11

Sponsor Name:CHU Caen

Full Title: SUPPLEMENTATION EN VITAMINE D CHEZ LES FEMMES MENOPAUSEES OSTEOPOROTIQUES: EVALUATION D’UN SCHEMA THERAPEUTIQUE DE NORMALISATION BIOLOGIQUE DU TAUX SERIQUE DE 25OHVITAMINE D

Medical condition: Femmes ménopausées de plus de 50 ans, ostéoporotiques avec ou sans fracture et ne recevant pas de vitamine D

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10031285	Osteoporosis postmenopausal	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-023543-15	Sponsor Protocol Number: CL09002	Start Date*: 2011-01-24
Sponsor Name:BioCis Pharma Oy
Full Title: Double-blind, placebo-controlled, multi-centre Phase II study to investigate dose response, safety, tolerability and efficacy of topical twice daily doses of 2.5% and 5% cis-urocanic acid in compar...
Medical condition: Chronic moderate or severe atopic dermatitis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2010-023562-51

Sponsor Protocol Number: BT-CL-PGG-CRC1031

Start Date*: 2011-11-17

Sponsor Name:Biothera

Full Title: A Phase 3 Open-Label, Randomized, Multicenter Study of Imprime PGG® in Combination with Cetuximab (Erbitux®) in Subjects with Recurrent or Progressive KRAS Wild Type Colorectal Cancer

Medical condition: Recurrent or Progressive KRAS Wild Type Colorectal Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10010030	Colorectal cancer recurrent	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-010804-27	Sponsor Protocol Number: PRIN 2007TFYZKF_002	Start Date*: 2009-06-01
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA
Full Title: ROLE OF NITRIC OXIDE IN LUNG INFLAMMATION OF COPD PATIENTS
Medical condition: COPD
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2009-010808-28

Sponsor Protocol Number: HBV BID

Start Date*: 2010-02-10

Sponsor Name:Kings College Hospital NHS Foundation Trust [...]

Full Title: Role of Non-invasive test in detecting fibrosis in chronic hepatitis B patients

Medical condition: Level of fibrosis in patients with chronic Hepatitis B(HBV).

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10016648	Fibrosis Liver	LLT
	12.0		10008910	Chronic hepatitis B	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2009-010811-34	Sponsor Protocol Number: 113018	Start Date*: 2009-04-16
Sponsor Name:GlaxoSmithKline Biologicals
Full Title: A Phase III, open, non-randomized, multi-centric, single dose study to assess mmunogenicity and safety of Fluarix / Influsplit SSW® 2009/2010 injected intramuscularly in young adults (18 to 60 year...
Medical condition: Immunization against influenza of healthy adults.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2009-010825-37

Sponsor Protocol Number: CRFB002DES01

Start Date*: 2009-06-29

Sponsor Name:Novartis Farmaceutica S.A

Full Title: Ensayo clínico de fase II, controlado, abierto, aleatorizado y multicéntrico, para comparar la eficacia y la seguridad de ranibizumab (inyección intravítrea) frente a fotocoagulación láser en pacie...

Medical condition: Edema macular diabético

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10057915	Diabetic macular oedema	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2009-015883-32

Sponsor Protocol Number: 28431754DIA3005

Start Date*: 2010-02-18

Sponsor Name:Janssen-Cilag International NV

Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin as Monotherapy in the Treatment of Subjects Wit...

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10027433 - Metabolism and nutrition disorders	10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed) SE (Completed) ES (Completed) IS (Completed) EE (Completed) AT (Completed)

Trial results: View results

EudraCT Number: 2009-014944-13

Sponsor Protocol Number: 242-08-210

Start Date*: 2009-11-06

Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc.

Full Title: A Phase 2, Multi-center, Non-controlled, Open-label Dose Escalation Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Orally Administered OPC-67683 Two Times Daily to Pati...

Medical condition: Pulmonary Multidrug-resistant Tuberculosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10037440	Pulmonary tuberculosis	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: LV (Completed) LT (Completed)

Trial results: View results

EudraCT Number: 2008-002362-66	Sponsor Protocol Number: 111738	Start Date*: 2008-09-03
Sponsor Name:GlaxoSmithKline Biologicals
Full Title: A phase III, observer-blind, multi-country, multi-centre study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals FLU NG vaccine compared to the referenc...
Medical condition: Immunization against influenza in male and female subjects aged 66 years or older and 19-43 years of age.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Completed) BE (Completed)
Trial results: View results

EudraCT Number: 2008-002369-29	Sponsor Protocol Number: T08	Start Date*: 2008-08-20
Sponsor Name:MSE Pharmazeutika GmbH
Full Title: Randomized, double-blind study of nanoquinone versus placebo in patients with tinnitus aurium and low baseline blood levels of Q10
Medical condition: Patients with tinnitus aurium and low blood levels of Q10
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-002380-14	Sponsor Protocol Number: P071204	Start Date*: Information not available in EudraCT
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Full Title: Protocole n° 2 de thérapie génique du déficit immunitaire combiné sévère lié à l’X (DISC-X1) lié à l’X (DISC-X1) à l’aide d’un vecteur rétroviral sécurisé
Medical condition: Déficit immunitaire lié à l'X
Disease:
Population Age: Newborns, Infants and toddlers, Children, Under 18		Gender:
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-002381-55

Sponsor Protocol Number: ROC-RIT-2007-02

Start Date*: 2009-06-16

Sponsor Name:ROCHE FARMA, S.A.

Full Title: Evaluación de la Eficacia de Rituximab en pacientes con Artritis Reumatoide a través de la medición, por Resonancia Magnética de Mano, de los parámetros clínicos de la enfermedad. Estudio RESONAR. ...

Medical condition: Pacientes con artritis reumatoide (AR) activa refractarios a uno o más fármacos antiTNF (definido por un DAS28>3,2).

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10039073	Rheumatoid arthritis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-016378-34

Sponsor Protocol Number: MI-CP204

Start Date*: 2010-06-30

Sponsor Name:MedImmune LLC

Full Title: An Open Label, Phase 1/2 Study of MEDI-551, a Humanized Monoclonal Antibody Directed Against CD19, in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Medical condition: Relapsed or refractory advanced B-cell malignancies: chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), B-cell non-Hodgkin’s lymphoma (NHL) (subtypes: follicular lymphoma (FL)...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008976	Chronic lymphocytic leukemia	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10067070	Follicular B-cell non-Hodgkin's lymphoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10012818	Diffuse large B-cell lymphoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) FR (Completed)

Trial results: View results

EudraCT Number: 2009-011828-64	Sponsor Protocol Number: FRS-AN2009-03-26	Start Date*: 2009-08-03
Sponsor Name:Anesthesiological dep., Hospital of Frederikssund
Full Title: Spinalanæstesi til knæartroskopi: Kan tilsætning af Lidokain til Bupivacain forkorte blokadens varighed?
Medical condition: Duration of nerve blockade after spinal anesthesia with either bupivacaine or a mixture of bupivacaine/lidocaine.
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: DK (Completed)
Trial results: (No results available)

EudraCT Number: 2009-011856-23

Sponsor Protocol Number: ERNPL

Start Date*: 2009-09-16

Sponsor Name:OSPEDALE POLICLINICO S. MATTEO

Full Title: Evaluation of acute postsurgery pain management in patients who undergo inguen hernia surgery

Medical condition: Acute post surgery pain in patients who undergo inguen hernia surgery

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10019917		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2009-011382-80	Sponsor Protocol Number:	Start Date*: 2009-06-22
Sponsor Name:Nottingham University Hospital
Full Title: Intravenous Iron: biomarkers and treatment strategies in anaemic Colorectal cancer patients.
Medical condition: Anaemia (specifically related to surgical pathology)
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue Sep 02 20:48:32 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA